Harvard Bioscience ROE 2010-2023 | HBIO

Current and historical return on equity (ROE) values for Harvard Bioscience (HBIO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Harvard Bioscience ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $-0.00B $0.07B -4.05%
2023-09-30 $-0.00B $0.07B -4.07%
2023-06-30 $-0.01B $0.08B -6.83%
2023-03-31 $-0.00B $0.07B -2.70%
2022-12-31 $-0.01B $0.07B -13.42%
2022-09-30 $-0.01B $0.07B -9.06%
2022-06-30 $-0.00B $0.08B -5.10%
2022-03-31 $-0.01B $0.08B -7.62%
2021-12-31 $0.00B $0.08B 0.00%
2021-09-30 $-0.00B $0.08B -2.58%
2021-06-30 $-0.00B $0.08B -3.87%
2021-03-31 $-0.01B $0.08B -6.51%
2020-12-31 $-0.01B $0.08B -11.76%
2020-09-30 $-0.01B $0.08B -9.00%
2020-06-30 $-0.01B $0.08B -11.58%
2020-03-31 $-0.01B $0.08B -8.89%
2019-12-31 $-0.00B $0.08B -5.02%
2019-09-30 $-0.00B $0.08B -2.50%
2019-06-30 $0.00B $0.08B 1.23%
2019-03-31 $0.00B $0.08B 0.00%
2018-12-31 $-0.00B $0.08B -2.50%
2018-09-30 $-0.00B $0.08B -5.03%
2018-06-30 $-0.00B $0.08B -5.10%
2018-03-31 $-0.00B $0.08B -3.85%
2017-12-31 $0.00B $0.08B 0.00%
2017-09-30 $-0.00B $0.08B -2.69%
2017-06-30 $-0.00B $0.08B -5.41%
2017-03-31 $-0.01B $0.07B -6.71%
2016-12-31 $-0.01B $0.07B -6.60%
2016-09-30 $-0.02B $0.08B -27.18%
2016-06-30 $-0.02B $0.08B -24.46%
2016-03-31 $-0.02B $0.08B -22.03%
2015-12-31 $-0.02B $0.08B -21.23%
2015-09-30 $-0.00B $0.09B -2.13%
2015-06-30 $0.00B $0.10B 0.00%
2015-03-31 $0.00B $0.09B 1.05%
2014-12-31 $0.00B $0.10B 3.11%
2014-09-30 $0.00B $0.10B 2.08%
2014-06-30 $0.00B $0.10B 0.00%
2014-03-31 $-0.00B $0.10B -0.99%
2013-12-31 $-0.00B $0.09B -1.95%
2013-09-30 $0.00B $0.11B 0.00%
2013-06-30 $0.00B $0.11B 0.97%
2013-03-31 $0.00B $0.10B 1.97%
2012-12-31 $0.00B $0.10B 3.00%
2012-09-30 $0.00B $0.10B 3.07%
2012-06-30 $0.00B $0.10B 3.10%
2012-03-31 $0.00B $0.10B 3.11%
2011-12-31 $0.00B $0.10B 4.19%
2011-09-30 $0.01B $0.10B 5.31%
2011-06-30 $0.02B $0.10B 19.51%
2011-03-31 $0.02B $0.09B 21.90%
2010-12-31 $0.02B $0.09B 23.10%
2010-09-30 $0.02B $0.09B 26.75%
2010-06-30 $0.01B $0.08B 12.08%
2010-03-31 $0.01B $0.08B 9.56%
2009-12-31 $0.01B $0.08B 9.86%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71